Curcumin, a major component of food spice turmeric (Curcuma longa), inhibits aggregation and alters eicosanoid metabolism in human blood platelets.
K.C. Srivastava; A. Bordia; S.K. Verma
Abstract
In traditional medicine, Ayurveda, several spices and herbs are held to possess medicinal properties. Earlier we have
reported that extracts from several spices, including turmeric, inhibit platelet aggregation and modulate eicosanoid
biosynthesis. Due to their eicosanoid-modulating property, it was suggested that the spices may serve to provide clues to
drugs directed to arachidonic acid (AA) pathway enzymes as pharmacological targets. Curcumin, a major component of
turmeric, inhibited platelet aggregation induced by arachidonate, adrenaline and collagen. This compound inhibited
thromboxane B2 (TXB2) production from exogenous [14C] arachidonate in washed platelets with a concomitant
increase in the formation of 12-lipoxygenase products. Moreover, curcumin inhibited the incorporation of [14C] AA into
platelet phospholipids and inhibited the deacylation of AA-labelled phospholipids (liberation of free AA) on stimulation
with calcium ionophore A23187. Curcumin`s anti-inflammatory property may, in part, be explained by its effects on
eicosanoid biosynthesis.